Eoin Paul Flanagan MD MB.BCh

Neuroimmunology/Multiple Sclerosis

Professor of Neurology, Department of Neurology, Mayo Clinic

Summary

Dr Eoin Flanagan is a Professor of Neurology and Consultant in the departments of Neurology and Laboratory Medicine and Pathology at the Mayo Clinic (Rochester, MN). He completed his medical school training at University College Dublin in Ireland in 2005. He did a medical residency in Ireland and then completed neurology residency, fellowships in neuroimmunology and a masters in clinical an translational science at Mayo Clinic (Rochester, MN). He works in the Autoimmune Neurology and Multiple Sclerosis Clinics and the Neuroimmunology Laboratory at the Mayo Clinic. His clinical expertise and research is focused on inflammatory myelopathies and their imaging patterns, Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated disorder, neuromyelitis optica spectrum disorders, autoimmune encephalitis, paraneoplastic neurologic disorders and multiple sclerosis. He is principal investigator on an NIH RO1 grant studying MOG antibody associated disorder.

Mayo School of Graduate Medical EducationM.S., Biomedical Sciences and Clinical and Translational Science, 2012 - 2016
Mayo Clinic College of Medicine and ScienceFellowship, Behavioral neurology, 2014 - 2015
Mayo Clinic College of Medicine and ScienceFellowship, Autoimmune Neurology, 2013 - 2014
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Neuroimmunology & Multiple Sclerosis, 2012 - 2013
Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 2009 - 2012

PubMed

Enterovirus Encephalitis in People With Multiple Sclerosis on Ocrelizumab: Insights From a Multicenter Case Series.
Samantha A Banks, Ilia Poliakov, Eoin P Flanagan, Michel Toledano, Nabeela Nathoo
Neurology(R) Neuroimmunology & Neuroinflammation. 2026-03-01
OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.
Thivya Pakeerathan, James Davis, Amanda D Henderson, Elias S Sotirchos, Yana Said
Neurology(R) Neuroimmunology & Neuroinflammation. 2026-03-01
The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of tumefactive demyelination.
Fiorella S Guido, John J Chen, Paul A Decker, Mahboubeh Fereidan-Esfahani, Kevin D Chodnicki
Journal of the Neurological Sciences. 2026-02-15

Journal Articles

Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated Disorders
Amy Kunchok, Brian G Weinshenker, Eoin P Flanagan, Sean J Pittock, JAMA Neurology
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis
Divyanshu Dubey, John Cheville, Thomas Kryzer, Chadwick Hales, Jorge Kattah, Eoin P Flanagan, Anastasia Zekeridou, Jenny J Linnoila, Andrew Mckeon, Sean J Pittock, JAMA Neurology
Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria
Allen J Aksamit, Karl N Krecke, Giuseppe Lanzino, Alejandro A Rabinstein, J D Bartleson, Melissa M Blessing, Nicholas L Zalewski, Timothy J Kaufmann, Brian G Weinshenk..., JAMA

Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated DisordersAugust 2020
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 EncephalitisAugust 2020
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 EncephalitisAugust 2020

Mayo Clinic Minute: Exercise Modifications Help Manage Multiple SclerosisDecember 9th, 2024
Our Top Five Favorite “ABCs of NMOSD” EpisodesMarch 16th, 2023
Multiple Sclerosis: A Primary Care PerspectiveFebruary 21st, 2023